{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T01:48:54Z","timestamp":1782092934165,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16120-0","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:10:11Z","timestamp":1777893011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High Ki-67 as an independent prognostic factor in extraskeletal osteosarcoma: a comparative cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"H\u00fclya Odaba\u015f\u0131","family":"B\u00fck\u00fcn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fcrkkan","family":"Evrensel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"\u00c7ubuk\u00e7u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adem","family":"Delig\u00f6n\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Bilgehan","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ender Eren","family":"\u00d6z\u00e7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer Can","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dclviye","family":"Yal\u00e7\u0131nkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyit Ali Volkan","family":"Polatkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"16120_CR1","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1002\/1097-0142(19951201)76:11<2253::AID-CNCR2820761112>3.0.CO;2-8","volume":"76","author":"J Lee","year":"1995","unstructured":"Lee J, Fetsch J, Wasdhal D, Lee B, Pritchard D, Nascimento A. A review of 40 patients with extraskeletal osteosarcoma. Cancer. 1995;76:2253\u20139. https:\/\/doi.org\/10.1002\/1097-0142(19951201)76:11%253C2253.","journal-title":"Cancer"},{"key":"16120_CR2","doi-asserted-by":"publisher","unstructured":"Bielack S, Carrle D, Casali P, ESMO Guidelines Working Group. Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology: official journal of the European Society for Medical Oncology. 2009;20 Suppl 4 SUPPL. 4:137\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdp154","DOI":"10.1093\/annonc\/mdp154"},{"key":"16120_CR3","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/1097-0142(19870901","volume":"60","author":"E Chung","year":"1987","unstructured":"Chung E, Enzinger F. Extraskeletal osteosarcoma. Cancer. 1987;60:1132\u201342. https:\/\/doi.org\/10.1002\/1097-0142(19870901. )60:5%253C1132::aid-cncr2820600536%253E3.0.co;2-l.","journal-title":"Cancer"},{"key":"16120_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3941\/jrcr.v7i7.1245","volume":"7","author":"M Hoch","year":"2013","unstructured":"Hoch M, Ali S, Agrawal S, Wang C, Khurana J. Extraskeletal osteosarcoma: a case report and review of the literature. J Radiol case Rep. 2013;7:15\u201323. https:\/\/doi.org\/10.3941\/jrcr.v7i7.1245.","journal-title":"J Radiol case Rep"},{"key":"16120_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ctrv.2013.11.006","volume":"40","author":"A Luetke","year":"2014","unstructured":"Luetke A, Meyers P, Lewis I, Juergens H. Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat Rev. 2014;40:523\u201332. https:\/\/doi.org\/10.1016\/j.ctrv.2013.11.006.","journal-title":"Cancer Treat Rev"},{"key":"16120_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.4103\/0301-4738.97555","volume":"64","author":"V de Maeyer","year":"2016","unstructured":"de Maeyer V, Kestelyn P, Shah A, Van Den Broecke C, Denys H, Decock C. Extraskeletal osteosarcoma of the orbit: A clinicopathologic case report and review of literature. Indian J Ophthalmol. 2016;64:687\u20139. https:\/\/doi.org\/10.4103\/0301-4738.97555.","journal-title":"Indian J Ophthalmol"},{"key":"16120_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00256-022-04193-4","volume":"52","author":"S Hesni","year":"2023","unstructured":"Hesni S, Lindsay D, O\u2019Donnell P, Saifuddin A. Extra-skeletal osteosarcoma: a review. Skeletal Radiol. 2023;52:633\u201348. https:\/\/doi.org\/10.1007\/s00256-022-04193-4.","journal-title":"Skeletal Radiol"},{"key":"16120_CR8","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10147-019-01475-1","volume":"24","author":"T Wakamatsu","year":"2019","unstructured":"Wakamatsu T, Kakunaga S, Takenaka S, Outani H, Hamada K, Imura Y, et al. Prognostic implication of adjuvant\/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma. Int J Clin Oncol. 2019;24:1311\u20139. https:\/\/doi.org\/10.1007\/s10147-019-01475-1.","journal-title":"Int J Clin Oncol"},{"key":"16120_CR9","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/j.asjsur.2024.10.058","volume":"48","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Wu Y, Cheng X, Zhao B. Survival benefit and impact of radiotherapy in extraskeletal osteosarcoma patients: A retrospective cohort study with propensity score matching. Asian J Surg. 2024;48:2487\u201390. https:\/\/doi.org\/10.1016\/j.asjsur.2024.10.058.","journal-title":"Asian J Surg"},{"key":"16120_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1200\/jco.20.2.521","volume":"20","author":"S Ahmad","year":"2002","unstructured":"Ahmad S. Extraosseous osteosarcoma: response to treatment and long-term outcome. J Clin Oncol. 2002;20:521\u20137. https:\/\/doi.org\/10.1200\/jco.20.2.521.","journal-title":"J Clin Oncol"},{"key":"16120_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/his.12138","volume":"63","author":"JR Conner","year":"2013","unstructured":"Conner JR, Hornick JL. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology. 2013;63:36\u201349.","journal-title":"Histopathology"},{"key":"16120_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/PAS.0000000000000412","volume":"39","author":"A Righi","year":"2015","unstructured":"Righi A, Gambarotti M, Longo S, Benini S, Gamberi G, Cocchi S. Small cell osteosarcoma: Clinicopathologic, immunohistochemical, and molecular analysis of 36 cases. Am J Surg Pathol. 2015;39:691\u20139.","journal-title":"Am J Surg Pathol"},{"key":"16120_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejca.2016.12.016","volume":"74","author":"A Longhi","year":"2017","unstructured":"Longhi A, Bielack S, Grimer R, Whelan J, Windhager R, Leithner A, et al. Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients. Eur J cancer (Oxford England: 1990). 2017;74:9\u201316. https:\/\/doi.org\/10.1016\/j.ejca.2016.12.016.","journal-title":"Eur J cancer (Oxford England: 1990)"},{"key":"16120_CR14","doi-asserted-by":"publisher","unstructured":"Niculescu \u015e, Grecu D, Simionescu C, Niculescu E, Stepan M, Stepan A. Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas. Romanian journal of morphology and embryology\u2009=\u2009Revue roumaine de morphologie et embryologie. 2021;62:743\u201350. https:\/\/doi.org\/10.47162\/RJME.62.3.11","DOI":"10.47162\/RJME.62.3.11"},{"key":"16120_CR15","doi-asserted-by":"publisher","first-page":"7776","DOI":"10.62347\/KTYO7957","volume":"17","author":"Z Gu","year":"2025","unstructured":"Gu Z, Zhang S, Li G, Hu X, Xu N, Wang Y, et al. Relationship between Ki-67 and P53 immunohistochemical expression and osteosarcoma chemotherapy sensitivity and long-term prognosis. Am J translational Res. 2025;17:7776\u201388. https:\/\/doi.org\/10.62347\/KTYO7957.","journal-title":"Am J translational Res"},{"key":"16120_CR16","doi-asserted-by":"publisher","first-page":"jcs258932","DOI":"10.1242\/jcs.258932","volume":"135","author":"N Andr\u00e9s-S\u00e1nchez","year":"2022","unstructured":"Andr\u00e9s-S\u00e1nchez N, Fisher D, Krasinska L. Physiological functions and roles in cancer of the proliferation marker Ki-67. J Cell Sci. 2022;135:jcs258932. https:\/\/doi.org\/10.1242\/jcs.258932.","journal-title":"J Cell Sci"},{"key":"16120_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12885-021-07880-y","volume":"21","author":"M Zeng","year":"2021","unstructured":"Zeng M, Zhou J, Wen L, Zhu Y, Luo Y, Wang W. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma. BMC Cancer. 2021;21:210. https:\/\/doi.org\/10.1186\/s12885-021-07880-y.","journal-title":"BMC Cancer"},{"key":"16120_CR18","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1016\/j.asjsur.2022.06.130","volume":"45","author":"Y Chen","year":"2022","unstructured":"Chen Y, Liu J, Zhou B, Yang M, Feng H. The value of Ki-67 as a prognostic biomarker in osteosarcoma: A systematic review and meta-analysis. Asian J Surg. 2022;45:2978\u201380. https:\/\/doi.org\/10.1016\/j.asjsur.2022.06.130.","journal-title":"Asian J Surg"},{"key":"16120_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.17305\/bjbms.2020.5437","volume":"21","author":"B Ocak","year":"2021","unstructured":"Ocak B, Atalay F, Sahin A, Ozsen M, Dakiki B, T\u00fcre S, et al. The impact of Ki-67 index, squamous differentiation, and several clinicopathologic parameters on the recurrence of low and intermediate-risk endometrial cancer. Bosnian J basic Med Sci. 2021;21:549\u201354. https:\/\/doi.org\/10.17305\/bjbms.2020.5437.","journal-title":"Bosnian J basic Med Sci"},{"key":"16120_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12957-016-0869-6","volume":"14","author":"K Tanaka","year":"2016","unstructured":"Tanaka K, Hasegawa T, Nojima T, Oda Y, Mizusawa J, Fukuda H, Iwamoto Y. Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304. World J Surg Oncol. 2016;14:110. https:\/\/doi.org\/10.1186\/s12957-016-0869-6.","journal-title":"World J Surg Oncol"},{"key":"16120_CR21","doi-asserted-by":"publisher","first-page":"687878","DOI":"10.3389\/fonc.2021.687878","volume":"11","author":"P Wang","year":"2021","unstructured":"Wang P, Li H, Hu Y, Peng X, Ye X, Xu D, Li A. Relationship Between Ultrasound Features and Ki-67 Labeling Index of Soft Tissue Sarcoma. Front Oncol. 2021;11:687878. https:\/\/doi.org\/10.3389\/fonc.2021.687878.","journal-title":"Front Oncol"},{"issue":"4","key":"16120_CR22","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/1097-0142(20010815)92:4<869::aid-cncr1395>3.0.co;2-u","volume":"92","author":"A Hoos","year":"2001","unstructured":"Hoos A, Stojadinovic A, Mastorides S, Urist MJ, Polsky D, Di Como CJ, Brennan MF, Cordon-Cardo C. High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomas. Cancer. 2001;92(4):869\u201374. https:\/\/doi.org\/10.1002\/1097-0142(20010815)92:4%3C;869::AID-CNCR1395%3E;3.0.CO;2-U.","journal-title":"Cancer"},{"issue":"1\u20132","key":"16120_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1155\/S1357714X00000086","volume":"4","author":"R Jong","year":"2000","unstructured":"Jong R, Davis AM, Mendes MG, Wunder JS, Bell RS, Kandel R. Proliferative activity (ki-67 expression) and outcome in high grade osteosarcoma: a study of 27 cases. Sarcoma. 2000;4(1\u20132):47\u201355. https:\/\/doi.org\/10.1155\/S1357714X00000086.","journal-title":"Sarcoma"},{"issue":"5","key":"16120_CR24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/00000478-199805000-00010","volume":"22","author":"M Lidang Jensen","year":"1998","unstructured":"Lidang Jensen M, Schumacher B, Myhre Jensen O, Steen Nielsen O, Keller J. Extraskeletal osteosarcomas: a clinicopathologic study of 25 cases. Am J Surg Pathol. 1998;22(5):588\u201394. https:\/\/doi.org\/10.1097\/00000478-199805000-00010.","journal-title":"Am J Surg Pathol"},{"key":"16120_CR25","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.prp.2014.05.010","volume":"210","author":"A von Baer","year":"2014","unstructured":"von Baer A, Ehrhardt A, Baumhoer D, Mayer-Steinacker R, Schultheiss M, Abdul-Nou T, et al. Immunohistochemical and FISH analysis of MDM2 and CDK4 in a dedifferentiated extraskeletal osteosarcoma arising in the vastus lateralis muscle: differential diagnosis and diagnostic algorithm. Pathol Res Pract. 2014;210:698\u2013703. https:\/\/doi.org\/10.1016\/j.prp.2014.05.010.","journal-title":"Pathol Res Pract"},{"key":"16120_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/his.13506","volume":"73","author":"N Makise","year":"2018","unstructured":"Makise N, Sekimizu M, Kubo T, Wakai S, Watanabe SI, Kato T, et al. Extraskeletal osteosarcoma: MDM2 and H3K27me3 analysis of 19 cases suggest disease heterogeneity. Histopathology. 2018;73:147\u201356.","journal-title":"Histopathology"},{"key":"16120_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12885-023-11731-3","volume":"24","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang L, Lin J, Huang X, Liang J, Zhong J, et al. Imaging diagnosis and differential diagnosis of extraskeletal osteosarcoma. BMC Cancer. 2024;24:11. https:\/\/doi.org\/10.1186\/s12885-023-11731-3.","journal-title":"BMC Cancer"},{"key":"16120_CR28","doi-asserted-by":"publisher","unstructured":"Tsukamoto S, Mavrogenis A, Angelelli L, Righi A, Filardo G, Kido A, et al. The Effect of Adjuvant Chemotherapy on Localized Extraskeletal Osteosarcoma: A Systematic Review. Cancers. 2022;14. https:\/\/doi.org\/10.3390\/cancers14102559.","DOI":"10.3390\/cancers14102559"},{"key":"16120_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejca.2019.07.029","volume":"125","author":"M Heng","year":"2020","unstructured":"Heng M, Gupta A, Chung P, Healey J, Vaynrub M, Rose P, et al. The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma. Eur J cancer (Oxford England: 1990). 2020;125:130\u201341. https:\/\/doi.org\/10.1016\/j.ejca.2019.07.029.","journal-title":"Eur J cancer (Oxford England: 1990)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16120-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16120-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16120-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T01:32:04Z","timestamp":1782091924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16120-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16120"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16120-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Health Research Ethics Committee of Uluda\u011f University Faculty of Medicine (Decision No: 2025\/5\u201327, Date: March 5, 2025). The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"763"}}